| 000 | 01679 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250518072042.0 | ||
| 264 | 0 | _c20200423 | |
| 008 | 202004s 0 0 eng d | ||
| 022 | _a1469-493X | ||
| 024 | 7 |
_a10.1002/14651858.CD013487 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPiechotta, Vanessa | |
| 245 | 0 | 0 |
_aMultiple drug combinations of bortezomib, lenalidomide, and thalidomide for first-line treatment in adults with transplant-ineligible multiple myeloma: a network meta-analysis. _h[electronic resource] |
| 260 |
_bThe Cochrane database of systematic reviews _c11 2019 |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Systematic Review | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBortezomib _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLenalidomide _xtherapeutic use |
| 650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
| 650 | 0 | 4 | _aNetwork Meta-Analysis |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aThalidomide _xtherapeutic use |
| 700 | 1 | _aJakob, Tina | |
| 700 | 1 | _aLanger, Peter | |
| 700 | 1 | _aMonsef, Ina | |
| 700 | 1 | _aScheid, Christof | |
| 700 | 1 | _aEstcourt, Lise J | |
| 700 | 1 | _aOcheni, Sunday | |
| 700 | 1 | _aTheurich, Sebastian | |
| 700 | 1 | _aKuhr, Kathrin | |
| 700 | 1 | _aScheckel, Benjamin | |
| 700 | 1 | _aAdams, Anne | |
| 700 | 1 | _aSkoetz, Nicole | |
| 773 | 0 |
_tThe Cochrane database of systematic reviews _gvol. 2019 _gno. 11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/14651858.CD013487 _zAvailable from publisher's website |
| 999 |
_c30349842 _d30349842 |
||